Insmed Inc (INSM)
25.97
-0.41
(-1.55%)
USD |
NASDAQ |
May 10, 16:00
25.97
0.00 (0.00%)
After-Hours: 20:00
Insmed Market Cap: 3.856B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 3.917B |
| May 08, 2024 | 3.861B |
| May 07, 2024 | 3.873B |
| May 06, 2024 | 3.853B |
| May 03, 2024 | 3.794B |
| May 02, 2024 | 3.810B |
| May 01, 2024 | 3.800B |
| April 30, 2024 | 3.671B |
| April 29, 2024 | 3.712B |
| April 26, 2024 | 3.683B |
| April 25, 2024 | 3.700B |
| April 24, 2024 | 3.833B |
| April 23, 2024 | 3.752B |
| April 22, 2024 | 3.580B |
| April 19, 2024 | 3.611B |
| April 18, 2024 | 3.683B |
| April 17, 2024 | 3.888B |
| April 16, 2024 | 3.883B |
| April 15, 2024 | 3.983B |
| April 12, 2024 | 4.046B |
| April 11, 2024 | 4.241B |
| April 10, 2024 | 4.216B |
| April 09, 2024 | 4.159B |
| April 08, 2024 | 4.174B |
| April 05, 2024 | 4.107B |
| Date | Value |
|---|---|
| April 04, 2024 | 4.051B |
| April 03, 2024 | 4.110B |
| April 02, 2024 | 3.905B |
| April 01, 2024 | 3.968B |
| March 28, 2024 | 4.029B |
| March 27, 2024 | 4.057B |
| March 26, 2024 | 4.012B |
| March 25, 2024 | 4.009B |
| March 22, 2024 | 3.925B |
| March 21, 2024 | 3.911B |
| March 20, 2024 | 3.947B |
| March 19, 2024 | 3.880B |
| March 18, 2024 | 3.882B |
| March 15, 2024 | 3.819B |
| March 14, 2024 | 3.907B |
| March 13, 2024 | 4.134B |
| March 12, 2024 | 4.055B |
| March 11, 2024 | 4.021B |
| March 08, 2024 | 4.131B |
| March 07, 2024 | 4.124B |
| March 06, 2024 | 4.156B |
| March 05, 2024 | 4.131B |
| March 04, 2024 | 4.198B |
| March 01, 2024 | 4.167B |
| February 29, 2024 | 4.116B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.225B
Minimum
Mar 23 2020
4.552B
Maximum
Feb 08 2021
2.910B
Average
2.835B
Median
Aug 09 2021
Market Cap Benchmarks
| NeuroMetrix Inc | 8.860M |
| Intra-Cellular Therapies Inc | 6.858B |
| Rhythm Pharmaceuticals Inc | 2.382B |
| Amylyx Pharmaceuticals Inc | 118.96M |
| AN2 Therapeutics Inc | 72.78M |
Market Cap Related Metrics
| PS Ratio | 11.95 |
| PEG Ratio | -0.1317 |
| Price | 25.97 |
| Earnings Yield | -20.56% |
| PEGY Ratio | -0.1317 |